Zoetis Inc. (ZTS) Earnings Call Transcripts

Zoetis Inc.'s Latest Earnings Call - Q2 FY2026

In the second quarter of 2026, Zoetis Inc. reported revenues of $2.5 billion, reflecting a 1% decline on an organic operational basis, driven by a 7% drop in U.S. Companion Animal revenue. Adjusted net income decreased by 2% to $781 million. The company revised its full-year guidance, now expecting organic operational revenue growth to decline between 3% to 1%, and adjusted net income to fall between 9% to 5% year-over-year, indicating a more challenging market environment than previously anticipated.

Reported metrics

Guidance from management

Zoetis revised its full-year guidance, now expecting organic operational revenue growth to decline 3% to 1% and adjusted net income to decline 9% to 5%. This reflects the ongoing pressures in the Companion Animal segment and competitive dynamics in the market.

What management said

So I'll take the first part of your question, Jon. Certainly, you saw in the quarter, price was flat. You're seeing the impact of the gross-to-net responses that we've already covered on this call at length, at least, I won't repeat those. And so what that would translate into, if you look at the guidance we just issued, on the range, it could be in the 0% to negative 1%, potentially negative 2% as you get towards th...

Great. Thanks, everybody, for joining us today. And as always, really appreciate your questions and your interest in Zoetis. We know this is a moment that demands even greater focus and execution, and we look forward to keeping you updated on our progress. I also want to reiterate that we remain confident in the long-term fundamentals of animal health in the strength and differentiation of our portfolio and our pipel...

What analysts pressed on

Analysts expressed concerns about the sustainability of the Livestock segment's growth and the impact of competitive pricing pressures on the Companion Animal segment. There were also questions regarding the effectiveness of Zoetis' promotional strategies in maintaining market share amidst heightened competition.

Main topics on the call

• Revenue Decline in Companion Animal Segment — Zoetis experienced a 6% decline in Companion Animal revenue, primarily due to decreased veterinary clinic visits and increased competition. Management stated, "the category itself continued to soften" and emphasized the ...
• Livestock Segment Growth — The Livestock segment delivered strong results with an 11% revenue growth, driven by demand for cattle and poultry products. Management noted, "the fundamentals of our U.S. Livestock business remained solid," reinforcing...
• Revised Full-Year Guidance — Zoetis updated its full-year guidance, now expecting organic operational revenue growth to decline 3% to 1% and adjusted net income to decline 9% to 5%. Management indicated this change reflects "the market conditions we...
• Increased Competitive Pressure — Management highlighted intensified competition, particularly in the Dermatology and parasiticides categories, stating, "the nature of competition has changed" with new entrants using aggressive pricing strategies. This h...

Read the full Zoetis Inc. transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 78 Zoetis Inc. earnings call transcripts on record, spanning January 15, 2020 to August 6, 2026. Based on this history, Zoetis Inc. reports quarterly. The most recent call on file is dated August 6, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

ZTS

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Pharmaceuticals

Calls on record

78

First call

January 15, 2020

Most recent

August 6, 2026

Reporting cadence

quarterly